Initially approved for type 2 diabetes management, semaglutide has been repositioned and rebranded across three products: Ozempic (injectable, for diabetes), Rybelsus (oral tablet, for diabetes), and Wegovy (injectable, higher dose, for obesity)
This guide walks through the latest clinical evidence, including the 2025 SURMOUNT-5 head-to-head trial, so you can have an informed conversation with your provider
"The truth is, we do see some people lose [weight] on a microdose, but it's not overly common loss typically happens at higher doses," Dr
Levocarnitine, used by Alchemist Pharmacy, is an amino acid derivative involved in fatty acid transport into mitochondria for energy production